<unk>  refers to a regimen consisting of  rituximab, cyclophosphamide, and dexamethasone used to treat monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas. and autoimmune cytopenias associated with chronic lymphocytic leukemia.
RCD regimen
TIP regimen
COPP regimen
DCEP regimen
MOPP regimen
FMR regimen
R-MA regimen
IFL regimen